Free Trial
→ Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift (From Stansberry Research) (Ad) Free TALS Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

Talaris Therapeutics (TALS) Insider Trading & Ownership

Talaris Therapeutics logo
Compare

Talaris Therapeutics (NASDAQ:TALS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.50%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$2.18M
Get TALS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Talaris Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TALS Insider Buying and Selling by Quarter

Talaris Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2023Suzanne IldstadDirectorSell12,942$2.49$32,225.58  
6/12/2023Suzanne IldstadDirectorSell16,870$2.59$43,693.30  
6/9/2023Suzanne IldstadDirectorSell25,419$2.46$62,530.74  
6/7/2023Suzanne IldstadDirectorSell75,001$2.39$179,252.39  
6/5/2023Suzanne IldstadDirectorSell7,841$2.52$19,759.32  
6/1/2023Suzanne IldstadDirectorSell15,713$2.56$40,225.28  
4/21/2023Suzanne IldstadDirectorSell15,004$2.35$35,259.40  
4/19/2023Suzanne IldstadDirectorSell21,753$2.16$46,986.48  
4/17/2023Suzanne IldstadDirectorSell99,771$2.14$213,509.94  
3/17/2023Suzanne IldstadDirectorSell10,436$2.06$21,498.16  
3/1/2023Suzanne IldstadDirectorSell29$2.05$59.45  
2/21/2023Suzanne IldstadDirectorSell3,500$2.05$7,175.00  
2/16/2023Suzanne IldstadDirectorSell2,939$2.06$6,054.34  
8/22/2022Suzanne IldstadInsiderSell525,000$2.80$1,470,000.00  
(Data available from 1/1/2013 forward)

TALS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Talaris Therapeutics includes Suzanne Ildstad. Learn more on insiders at TALS.

16.50% of Talaris Therapeutics stock is owned by insiders. Learn more on TALS's insider holdings.


Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:TALS) was last updated on 7/30/2025 by MarketBeat.com Staff
From Our Partners
AI Frenzy Could Send ‘EarnPhone’ Soaring
The hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...
Mode Mobile | Sponsored
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...
Priority Gold | Sponsored
Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift
Trump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...
Stansberry Research | Sponsored
Nvidia’s next AI move could catch traders flat-footed
Tired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...
Timothy Sykes | Sponsored
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...
Porter & Company | Sponsored
Market Crash Warning: How to Protect Your Wealth Before August 12th
New China tariffs hit August 12th—and Wall Street’s already moving. Banks and billionaires are quietly shif...
American Alternative | Sponsored
Strange Investment Secret Predicts Market's Next Move?
A strange market signal discovered before the Great Depression has predicted nearly every major financial even...
Weiss Ratings | Sponsored
The $1 Trillion Event Tesla Still Hasn’t Recovered From
In 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...
Brownstone Research | Sponsored